The Patent Finder

Cancervax, Corp.

Also on record
Records under this name other than patents Cancervax, Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Cancervax, Corp.

PatentTitleStatus Expires Confidence
US 7,070,939Methods for detecting vasculopathies and tumors
Lapsed on the fee record
Ended Jul 4, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jul 4, 2014From the USPTO record
US 6,491,92635 kD tumor associated protein antigen: uses and methods of detection
Term ended
Term ended Apr 18, 2010 · From the USPTO record
Term endedTerm ended Apr 18, 2010From the USPTO record
US 7,097,84635 KD Tumor Associated Protein Antigen: Uses and Methods of Detection
Term ended
Term ended Apr 18, 2010 · Medium confidence
Term endedTerm ended Apr 18, 2010Medium confidence
US 5,840,317Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
Term ended
Term ended no later than Nov 24, 2018 · Low confidence
Term endedTerm ended no later than Nov 24, 2018Low confidence
US 5,882,654Polyvalent melanoma vaccine
Term ended
Term ended no later than Mar 16, 2019 · Low confidence
Term endedTerm ended no later than Mar 16, 2019Low confidence
US 5,993,828Tumor associated antigen compositions and methods
Term ended
Term ended no later than Nov 30, 2019 · Low confidence
Term endedTerm ended no later than Nov 30, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited